Zulieta, Aziz .

HRN: 24-88-81  Sex: Male

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
04/23/2024
MEBENDAZOLE 100MG/5ML, 60ML SUSPENSION
04/23/2024
04/26/2024
PO
5ml
BID
Ascariasis
Waiting Final Action 

Indication:  ProphylaxisEmpiric    Type of Infection:  Intra-abdominal    Compliance to guidelines: Compliant To Guidelines

Initial appropriateness: Yes   

Final appropriateness: Yes   

Overall appropriateness: Yes 

Intervention



Type of Intervention done:

                    

           


Acceptance: